South and Central America Epithelial Cell Culture Media Market is expected to reach US$ 15,745.91 thousand by 2028

The renal epithelial cell segment by product type is estimated to lead the market growth during the forecast period.

According to a new market research study of “South and Central America Epithelial Cell Culture Media Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product Type, End User and Country.” The South and Central America epithelial cell culture media market is expected to reach US$ 15,745.91 thousand by 2028 from US$ 7,862.71 thousand in 2021; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. The report highlights trends prevailing in the South and Central America epithelial cell culture media market and the factors driving market along with those that act as hindrances.

The South and Central America epithelial cell culture media market, by product type, is segmented human mammary epithelial cells, bronchia/trachea epithelial cells, renal epithelial cells, and others. The bronchia/trachea epithelial cells segment held the largest share of the market in 2020, whereas the renal epithelial cell segment is anticipated to register the highest CAGR in the market during the forecast period.

Epithelial cells are valuable in biology research to understand the function of living systems. For example, cervical epithelial cells provide an in vitro model for studying physiological processes associated with diseases such as cervical cancer, cervical polyps, and human papilloma virus (HPV) disease. Further, epithelial cell lines are used in studies of drug transport processes. Drug transport studies in epithelial cells can be performed easily under controlled conditions, and they generate of important information. With the increasing applications of epithelial cells, the demand for media required to culture these cell lines is also on rise, which is boosting the epithelial cell culture media market growth. Extensive funding for supporting the research projects involving the use of epithelial cells to identify new therapeutic solutions for chronic diseases are propelling the demand for epithelial cell culture media. Hence, the increase in such grants for epithelial cell-based research projects are favouring the epithelial cells culture market growth. Also, the huge presence and vigorous activities in biopharmaceuticals industries in different countries is creating opportunities for research and innovation, further attracting numerous public–private investments, which are creating significant growth opportunities for the epithelial cell culture media market players.

The outbreak of COVID–19 has strictly impacted medical services in the South and Central America region. The COVID-19 pandemic has negatively impacted all phases of drug development and forced many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. Moreover, the ongoing COVID-19 crisis is likely to put additional pressure on the market to meet the future demand for cell and gene therapies. Further in Latin America, the COVID-19 pandemic has disrupted scientific research activities significantly as the pharmaceutical companies and research institution have shifted their research activities on vaccine for COVID-19. Thus, above mentioned factors are expected to hinder the growth of the market for a certain time.

The growth of the market is attributed to some key driving factors such as increasing applications of epithelial cells and rising funds for epithelial cells research. However, risk of contamination, misidentification, and random alternations in cell lines is expected to obstruct the growth of the market to a certain extent during the forecast years.

Thermo Fisher Scientific Inc., PromoCell GmbH, MERCK KGaA, ATCC, Lonza, and BIO-TECHNE CORPORATION are among the leading companies operating in the South and Central America epithelial cell culture media market.

The report segments in South and Central America Epithelial Cell Culture Media Market as follows:

By Product Type

• Human Mammary Epithelial Cells
• Bronchia/Trachea Epithelial Cells
• Renal Epithelial Cells
• Others

By End User

• Biopharmaceutical Companies
• Academic and Research Laboratories
• Others

By Country

• Brazil
• Argentina
• Rest of South and Central America